The gating pore blocker 1-(2,4-xylyl)guanidinium selectively inhibits pacemaking of midbrain dopaminergic neurons.
Jehasse K, Massotte L, Hartmann S, Vitello R, Ringlet S, Vitello M, Chua HC, Pless SA, Engel D, Liégeois JF, Lakaye B, Roeper J, Seutin V.
Jehasse K, et al. Among authors: seutin v.
Neuropharmacology. 2021 Oct 1;197:108722. doi: 10.1016/j.neuropharm.2021.108722. Epub 2021 Jul 15.
Neuropharmacology. 2021.
PMID: 34273387
Free article.